Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes [0.03%]
器官移植供者多重耐药菌对受者的临床结局的影响
Judith A Anesi,Emily A Blumberg,Jennifer H Han et al.
Judith A Anesi et al.
Background: The impact of donor colonization or infection with multidrug-resistant organisms (MDROs) on solid organ transplant (SOT) recipient outcomes remains uncertain. We thus evaluated the association between donor MD...
Carbapenemase-producing Enterobacterales in solid organ transplantation: Tip of the iceberg? [0.03%]
器官移植受者中的产碳青霉烯酶肠杆菌科细菌感染：冰山一角？
Kyle C Molina,Valida Bajrovic,Robert A Bonomo
Kyle C Molina
A liver transplant recipient developed a urinary tract infection with Citrobacter freundii complex and Klebsiella aerogenes, both producing dual carbapenemases (KPC-3/NDM-1). Whole-genome sequencing suggested plasmid transfer between organi...
Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation [0.03%]
异基因单倍型相合造血干细胞移植后巨细胞病毒活性感染的治疗研究
Zhao Yin,Jing Sun,Ying Yang et al.
Zhao Yin et al.
Background: Cidofovir (CDV) is a nucleotide analogue with broad antiviral activities. It remains unclear about the CDV administration for anti-cytomegalovirus (CMV) treatment in patients with haploidentical hematopoietic ...
Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression [0.03%]
病毒：朋友还是敌人？以Torque Teno病毒和免疫抑制为例
Natalia Redondo,David Navarro,José María Aguado et al.
Natalia Redondo et al.
New reliable biomarkers are needed to improve individual risk assessment for post-transplant infection, acute graft rejection and other immune-related complications after solid organ transplantation (SOT) and allogeneic hematopoietic stem c...
Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy [0.03%]
实体器官移植受者接种新型冠状病毒疫苗后感染突破性新冠肺炎：症状性病例和单克隆抗体治疗分析
Zachary A Yetmar,Eric Bhaimia,Dennis M Bierle et al.
Zachary A Yetmar et al.
Background: Solid organ transplant (SOT) recipients are at increased risk for complications from SARS-CoV-2 infection. Little is known regarding clinical course and outcomes of breakthrough COVID-19 in the fully vaccinate...
Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients [0.03%]
肾移植受者COVID相关毛霉病的危险因素和结局
Shyam B Bansal,Abhyuday Rana,Mayur Babras et al.
Shyam B Bansal et al.
Background: Invasive mucormycosis (IM) is a life-threatening fungal infection occurring mostly in solid organ transplant (SOT) recipients, patients with hematological malignancies, and diabetes. A sudden spurt of mucormyc...
Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates [0.03%]
肾脏移植受者的人peg病毒1型感染：复制动力学和临床相关性
Mario Fernández-Ruiz,Lorena Forque,Eliseo Albert et al.
Mario Fernández-Ruiz et al.
Background: Increasing evidence suggests that infection with the nonpathogenic human pegivirus type 1 (HPgV-1) exerts a clinical benefit in human immunodeficiency virus (HIV) patients, which could be attributable to immun...
Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT [0.03%]
关于SARS-CoV-2无症状感染导致的细胞治疗推迟或非移植化疗的当前态度：EBMT传染病工作队调查结果
Jan Styczynski,Simone Cesaro,Marie von Lilienfeld-Toal et al.
Jan Styczynski et al.
The objective of the study was to assess the current clinical practice and the attitude toward deferral of HCT/chemotherapy in patients with hematological diseases in cases of asymptomatic patients with a positive assay for SARS-CoV-2. In A...
Caregiver exposure to hepatitis C virus following transplantation with hepatitis C viremic donor organs: A case series [0.03%]
丙型肝炎病毒阳性供体器官移植后照护者感染丙型肝炎病毒的病例系列研究报告
Michelle Kim,Jeffrey Stern,Ryan Robalino et al.
Michelle Kim et al.
Direct-acting antiviral (DAA) therapeutics have ushered in an era in which transplanting organs from donors infected with hepatitis C virus (HCV+) into recipients without (HCV-) is an increasingly common practice. Rare but potentially life-...
Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls [0.03%]
固体器官移植受者和健康对照者对SARS-CoV-2 BNT162b2疫苗的体液和细胞免疫反应
Ahmad Yanis,Zaid Haddadin,Andrew J Spieker et al.
Ahmad Yanis et al.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased morbidity and mortality in solid organ transplant (SOT) recipients. Despite exclusion from SARS-CoV-2 vaccine...